Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-masked crossover study of moxaverine versus placebo on ocular blood flow
2006-001783-23Phase 2Completed
- Sponsor
- URSAPHARM
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of moxaverine in ocular blood flow abnormality (2 arms), sponsored by URSAPHARM. Primary endpoints: Retinal blood flow, Choroidal blood flow and 1 more. Started Jul 2006; status: completed.
02
Drugs
moxaverine
03
Conditions
ocular blood flow abnormality
Beyond the preview
Go deeper on 2006-001783-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001783-23.